Literature DB >> 23398414

Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma.

M Kim, M Li, L R A Intong, K Tran, W Melbourne, D Marucci, J Bucci, P de Souza, G Mallesara, D F Murrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23398414     DOI： 10.1111/bjd.12272

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  9 in total

Review 1.  Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa.

Authors:  Ellie Rashidghamat; John A McGrath
Journal:  Intractable Rare Dis Res       Date:  2017-02

2.  Polymeric Nanoparticles to Combat Squamous Cell Carcinomas in Patients with Dystrophic Epidermolysis Bullosa.

Authors:  Martin A C Manoukian; Susanne V Ott; Jayakumar Rajadas; Mohammed Inayathullah
Journal:  Recent Pat Nanomed       Date:  2014

3.  Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years' experience of a reference centre in Spain.

Authors:  B Castelo; D Viñal; R Maseda; L Ostios; D Sánchez; B García-Salvatierra; M J Escámez; L Martínez-Santamaría; M Del Río; M Mora-Rillo; Y Vilches; M J Beato; J C López Gutiérrez; N Romero; C Santos; J Miranda; R de Lucas
Journal:  Clin Transl Oncol       Date:  2019-03-12       Impact factor: 3.405

Review 4.  Therapy of advanced squamous cell carcinoma of the skin.

Authors:  Claudia Bejar; Eve Maubec
Journal:  Curr Treat Options Oncol       Date:  2014-06

Review 5.  Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases.

Authors:  H Montaudié; C Chiaverini; E Sbidian; A Charlesworth; J-P Lacour
Journal:  Orphanet J Rare Dis       Date:  2016-08-20       Impact factor: 4.123

Review 6.  Molecular Therapeutics in Development for Epidermolysis Bullosa: Update 2020.

Authors:  Cristina Has; Andrew South; Jouni Uitto
Journal:  Mol Diagn Ther       Date:  2020-06       Impact factor: 4.074

Review 7.  Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives.

Authors:  Angelo Giuseppe Condorelli; Elena Dellambra; Elena Logli; Giovanna Zambruno; Daniele Castiglia
Journal:  Int J Mol Sci       Date:  2019-11-14       Impact factor: 5.923

Review 8.  Investigational Treatments for Epidermolysis Bullosa.

Authors:  Ping-Chen Hou; Han-Tang Wang; Stasha Abhee; Wei-Ting Tu; John A McGrath; Chao-Kai Hsu
Journal:  Am J Clin Dermatol       Date:  2021-07-22       Impact factor: 7.403

9.  Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study.

Authors:  Susan J Robertson; Elizabeth Orrin; Manpreet K Lakhan; Gavin O'Sullivan; Jessie Felton; Alistair Robson; Danielle T Greenblatt; Catina Bernardis; John A McGrath; Anna E Martinez; Jemima E Mellerio
Journal:  Acta Derm Venereol       Date:  2021-08-24       Impact factor: 3.875
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.